The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationCyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
SIMONNEAU, G., BARST, R. J., GALIE, N., NAEIJE, R., RICH, S., BOURGE, R. C., KEOGH, A., OUDIZ, R., FROST, A., BLACKBURN, S. D., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2106079 · Cited by 1,441
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Kyotani, S., Sakamaki, F., Kakishita, M., Fukushima, K., Okano, Y., Nakanishi, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.8.865 · Cited by 876
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationGaliè, N., Humbert, M., Vachiéry, J.-L., Vizza, C., Kneussl, M., Manes, A., Sitbon, O., Torbicki, A., Delcroix, M., Naeije, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01786-2 · Cited by 648
Beraprost therapy for pulmonary arterial hypertension
Barst, R. J., McGoon, M., McLaughlin, V., Tapson, V., Oudiz, R., Shapiro, S., Robbins, I. M., Channick, R., Badesch, D., Rayburn, B. K., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00463-7 · Cited by 631
Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K., & Archer, S. (2002) · Circulation · doi:10.1161/01.cir.0000016641.12984.dc · Cited by 577
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Ghofrani, H. A., Wiedemann, R., Rose, F., Olschewski, H., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00008 · Cited by 496
Self-citationBrock, G. B., McMahon, C. G., Chen, K. K., Costigan, T., Shen, W., Watkins, V., Anglin, G., & Whitaker, S. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64442-4 · Cited by 421
Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
Wilkens, H., Guth, A., König, J., Forestier, N., Cremers, B., Hennen, B., Böhm, M., & Sybrecht, G. W. (2001) · Circulation · doi:10.1161/hc3601.096826 · Cited by 392
Sitbon, O., Brenot, F., Denjean, A., Bergeron, A., Parent, F., Azarian, R., Herve, P., Raffestin, B., & Simonneau, G. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.2.7842196 · Cited by 315
Hoeper, M. M., Olschewski, H., Ghofrani, H. A., Wilkens, H., Winkler, J., Borst, M. M., Niedermeyer, J., Fabel, H., & Seeger, W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00494-5 · Cited by 313
Self-citationSitbon, O., Humbert, M., Jagot, J., Taravella, O., Fartoukh, M., Parent, F., Herve, P., & Simonneau, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020265 · Cited by 301
Gresser, U., & Gleiter, C. H. (2002) · PubMed · Cited by 268
Pharmacology of phosphodiesterase inhibitors
(2005) · Therapeutic Strategies in COPD · doi:10.1201/b14809-12 · Cited by 261
PHARMACOLOGY OF PHOSPHODIESTERASE‐5 INHIBITORS
Corbin, J., & Francis, S. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11296.x · Cited by 260
Saenz de Tejada, I., Angulo, J., Cuevas, P., Fernández, A., Moncada, I., Allona, A., Lledó, E., Körschen, H., Niewöhner, U., Haning, H., et al. (2001) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900726 · Cited by 232
Overview of phosphodiesterase 5 inhibition in erectile dysfunction
Rosen, R. C., & Kostis, J. B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00824-5 · Cited by 205
Hellstrom, W. J. G., Gittelman, M., KARLIN, G. S., Segerson, T. P., Thibonnier, M., Taylor, T., & Padma-Nathan, H. (2003) · Urology · doi:10.1016/s0090-4295(03)00115-8 · Cited by 148
IC351 (tadalafil, Cialis): update on clinical experience
Porst, H. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900807 · Cited by 116
Cardiovascular Effects of Tadalafil
Kloner, R. A., Mitchell, M., & Emmick, J. T. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00074-2 · Cited by 102
Ca/CaM-Stimulated and cGMP-Specific Phosphodiesterases in Vascular and Non-Vascular Tissues
Ahn, H. S., Foster, M., Cable, M., Pitts, B. J. R., & Sybertz, E. J. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-6015-5_15 · Cited by 81
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists
Francis, S. H., & Corbin, J. D. (2003) · Current Urology Reports · doi:10.1007/s11934-003-0027-x · Cited by 68
Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension
Wiedemann, R., Ghofrani, H. A., Weißmann, N., SCHERMULY, R. T., Quanz, K., Grimminger, F., Seeger, W., & Olschewski, H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01490-5 · Cited by 58
Self-citationYoung, J. M. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1487 · Cited by 35
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
Self-citation
Metadata
- Authors
- Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Olschewski, H., Haredza, P., Karadaş, B., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 44
- Issue
- 7
- Pages
- 1488-1496
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2035736227
- Cited by
- 286
- References
- 28
- FWCI
- 22.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.